The use of aripiprazole for tic disorders in children and adolescents and implications for resource limited settings in the developing world

Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/18570

Full metadata record

DC Field	Value	Language
dc.contributor.author	Chandradasa, M.	en_US
dc.contributor.author	Champika, L.	en_US
dc.date.accessioned	2018-01-02T10:24:54Z	en_US
dc.date.available	2018-01-02T10:24:54Z	en_US
dc.date.issued	2018	en_US
dc.identifier.citation	Psychiatry Research. 2018;263:298.	en_US
dc.identifier.issn	0165-1781 (Print)	en_US
dc.identifier.issn	1872-7123 (Electronic)	en_US
dc.identifier.issn	0165-1781 (Linking)	en_US
dc.identifier.uri	http://repository.kln.ac.lk/handle/123456789/18570	en_US
dc.description	Indexed In MEDLINE	en_US
dc.description.abstract	Comment On: The efficacy and safety of aripiprazole for tic disorders in children and adolescents: a systematic review and meta-analysis. [Psychiatry Res. 2017 ;254:24-32.]	en
dc.language.iso	en_US	en_US
dc.publisher	Elsevier	en_US
dc.subject	Tic disorder	en_US
dc.title	The use of aripiprazole for tic disorders in children and adolescents and implications for resource limited settings in the developing world	en_US
dc.type	Comment	en_US
Appears in Collections:	Journal/Magazine Articles

Files in This Item:

There are no files associated with this item.

DSpace JSPUI